Thromboprophylaxis for central venous catheters in cancer patients

Journal of Gynecologic Oncology Nursing

Volumn 16, Issue 3, 2006, Pages 9-17

  Segars, Kelly ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36348959055     PISSN: 15369935     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Abdelkefi, A., Othman, T.B., Kammoun, L., Chelli, M., Romdhane, N.B., et al. (2004). Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease: A randomized controlled trial. Thrombosis and Haemostasis, 92, 654-661.
2. Cortelezzi, A., Moia, M., Falanga, A., Pogliani, E.M., Agnelli, G. et al. (2005). Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: A prospective multicentre study. British Journal of Haematology, 129, 811-817.
3. Couban, S., Goodyear, M., Burnell, M., Dolan, S., Wasi, P., et al. (2005). Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. Journal of Clinical Oncology, 23(18), 4063-4069.
4. Cunningham, M.S., White, B., Hollywood, D., & O'Donnell, J. (2006). Primary thromboprophylaxis for cancer patients with central venous catheters - A reappraisal of the evidence. British Journal of Cancer, 94, 189-194.
5. Estes, J.M., Rocconi, R., Straughn, J.M., Bhoola, S., Leath, C.A., et al. (2003). Complications of in dwelling venous access devices in patients with gynecologic malignancies. Gynecologic Oncology, 91(3), 591-595.
6. Frank, J.L., Garb, J.L., Halla, B., & Reed, W.P. (2001). Ionic implantation of silicone chronic venous access devices does not alter thrombotic complications: A double-blinded, randomized clinical trial. Surgery, 129, 547-551.
7. Harter, C., Salwender, H.J., Bach, A., Egerer, G., Goldschmidt, H., et al. (2002). Catheter related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy: A prospective compare son of silver-coated and uncoated catheters. Cancer, 94, 245-251.
8. Heaton, D.C., Han, D.Y., & Inder, A. (2002). Mididose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Internal Medicine Journal, 32, 84-88.
9. Karthaus, M., Kretzschmar, A., Kroning, H., Biakhov, M., Irwin, D., et al. (2006). Dalteparin for prevention of catheter related complications in cancer patients with central venous catheters: Final results of a double-blind, placebo-controlled phase III trial. Annals of Oncology, 17, 289-296.
10. Klerk, C.P.W., Smorenburg, S.M., & Buller, H.R. (2003). Thrombosis prophylaxis in patient populations with a central venous catheter. Archives of Internal Medicine, 163, 1913-1921.
11. Kuriakose, P., Colon-Otero, G., & Paz-Fumagalli, R. (2002). Risk of deep venous thrombosis associated with chest versus arm central venous sub cutaneous port catheters: A five-year single-institution retrospective study. Journal of Vascular Interventional Radiology, 13, 179-184.
12. Kuter, D. J. (2004). Thrombotic complications of central venous catheters in cancer patients. The Oncologist, 9, 207-216.
13. Luciani, A., Clement, O., Halimi, P., Goudot, D., Portier, F. et al. (2001). Catheter-related upper extremity deep venous thrombosis in cancer patients: A prospective study based on Doppler US. Radiology, 220, 655-660.
14. Minassian, V.A., Sood, A.K., Lowe, P., Sorosky, J.I., Al-Jurf, A.S., et al (2000). Longterm central venous access n gynecologic cancer patients. Journal of the American College of Surgery, 191(4), 403-409.
15. Mismetti, P., Mille, D., Laporte, S., Charlet, V., Buchmuller-Cordier, A., et al. (2003). Low-molecular-weight heparin (LMWH) (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: A pilot randomized trial. Haematologica, 88, 67-73.
16. Namyslowski, J. (2002). Management of catheter induced venous thrombosis. Techniques in Vascular and Interventional Radiology, 5(2), 85-88.
17. Tesselaar, M.E.T., Ouwerkerk, J., Nooy, M.A., Rosendaal, F.R., Osanto, S. (2004). Risk factors for catheter related thrombosis in cancer patients. European Journal of Cancer, 40, 2253-2259.
18. Verso, M. & Agnelli, G. (2003). Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. Journal of Clinical Oncology, 21(19), 3665-3675.
19. Verso, M., Agnelli, G., Bertoglio, S., Di Somma, F.C., Paoletti, F., et al. (2005). Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: A double-blind, placebo-controlled, randomized study in cancer patients. Journal of Clinical Oncology, 23(18), 4057-4062.
20. Viale, P.H. (2003). Complications associated with implantable vascular access devices in the patient with cancer. Journal of Infusion Nursing, 26(2), 97-102.
21. Wolosker, N., Yazbek, G., Nishinari, K., Malavolta, L.C., Munia, M.A. et al. (2004). Totally implantable venous catheters for chemotherapy: Experience in 500 patients. Sao Paulo Medical Journal, 122(4), 147-151.